Literature DB >> 8593699

Migration of arterial wall cells. Expression of plasminogen activators and inhibitors in injured rat arteries.

M A Reidy1, C Irvin, V Lindner.   

Abstract

The expression of plasminogen activators and inhibitors was examined in denuded arteries. Within 5 days, smooth muscle cells (SMCs) on the luminal surface expressed the mRNA for tissue-type plasminogen activator (TPA), urokinase type plasminogen (UPA), the receptor for UPA (UPAR), and plasminogen activator inhibitor type-1 (PAI-1). Similar results were seen after 8 days. Six weeks later, only TPA mRNA was still expressed by SMCs on the luminal surface. En face casein zymograms revealed a net fibrinolytic activity in areas covered with luminal SMCs. Reverse zymography showed no antifibrinolytic activity in these zones. Quiescent endothelial cells did not express TPA, UPA, UPAR, or PAI-1 mRNA. Regenerating endothelium at the wound edge strongly expressed TPA. UPA, and UPAR, as well as PAI-1. UPA and UPAR expression was highly restricted to cells at the wound edge and was not present elsewhere. En face zymography showed no plasmin activity in endothelialized areas, and reverse zymography showed a net fibrinolytic activity in endothelialized zones. These results suggest that plasminogen activator and inhibitor expression correlates with the migration of both SMCs and endothelial cells into an arterial wound.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8593699     DOI: 10.1161/01.res.78.3.405

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  11 in total

1.  Adenovirus-mediated expression of tissue plasminogen activator does not alter endothelial cell proliferation and invasion.

Authors:  D K Zablocki; J J Rade; B R Alevriadou
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Nov-Dec       Impact factor: 2.416

2.  Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion.

Authors:  Andrew S Gilder; Karra A Jones; Jingjing Hu; Lei Wang; Clark C Chen; Bob S Carter; Steven L Gonias
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

3.  Impaired arterial neointima formation in mice with disruption of the plasminogen gene.

Authors:  P Carmeliet; L Moons; V Ploplis; E Plow; D Collen
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

Review 4.  Plasmin activation system in restenosis: role in pathogenesis and clinical prediction?

Authors:  G Christ; K Kostner; M Zehetgruber; B R Binder; D Gulba; K Huber
Journal:  J Thromb Thrombolysis       Date:  1999-06       Impact factor: 2.300

5.  Polyelectrolyte nanoparticles mediate vascular gene delivery.

Authors:  Sergey Zaitsev; Régis Cartier; Oleg Vyborov; Gleb Sukhorukov; Bernd-Reiner Paulke; Annekathrin Haberland; Yelena Parfyonova; Vsevolod Tkachuk; Michael Böttger
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

Review 6.  The mechanisms of coronary restenosis: insights from experimental models.

Authors:  G A Ferns; T Y Avades
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

7.  Vascular disease in mice with a dysfunctional circadian clock.

Authors:  Ciprian B Anea; Maoxiang Zhang; David W Stepp; G Bryan Simkins; Guy Reed; David J Fulton; R Daniel Rudic
Journal:  Circulation       Date:  2009-03-09       Impact factor: 29.690

8.  Vascular injury triggers Krüppel-like factor 6 mobilization and cooperation with specificity protein 1 to promote endothelial activation through upregulation of the activin receptor-like kinase 1 gene.

Authors:  Eva M Garrido-Martín; Francisco J Blanco; Mercé Roquè; Laura Novensà; Mirko Tarocchi; Ursula E Lang; Toru Suzuki; Scott L Friedman; Luisa M Botella; Carmelo Bernabéu
Journal:  Circ Res       Date:  2012-10-09       Impact factor: 17.367

9.  Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.

Authors:  P Carmeliet; L Moons; M Dewerchin; S Rosenberg; J M Herbert; F Lupu; D Collen
Journal:  J Cell Biol       Date:  1998-01-12       Impact factor: 10.539

10.  Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction.

Authors:  Arman T Askari; Marie-Luise Brennan; Xiaorong Zhou; Jeanne Drinko; Annitta Morehead; James D Thomas; Eric J Topol; Stanley L Hazen; Marc S Penn
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.